Octiq Sodium Chloride Eye Ointment 

Octiq by

Drug Labeling and Warnings

Octiq by is a Otc medication manufactured, distributed, or labeled by Innovus Pharmaceuticals, Inc., AMMAN PHARMACEUTICAL INDUSTRIES. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

OCTIQ- sodium chloride ointment 
Innovus Pharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Octiq Sodium Chloride Eye Ointment 

Active ingredients

Sodium Chloride 5%

Purpose

Hypertonicity agent

Use

For the temporary relief of corneal edema

Warnings

• For use in the eyes only
• Retain outer carton for full product drug facts

Do not use 

this product except under the advice and supervision of a doctor

When using this product

• To avoid contamination, do not touch tip of container to any surface
• Replace cap after use
• This product may cause temporary burning and irritation on being instilled into the eye

Stop use and ask a doctor if

• You experience eye pain, changes in vision, continued redness or irritation of the eye 
• Condition worsens or persists for more than 72 hours

Keep out of reach of children 

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• pull down lower lid of the affected eye(s) and apply a small amount (1/4 inch) to the inside of the eyelid 
• apply every 3 - 4 hours, or as directed by a doctor.

Other Information 

• Store at room temperature 15°C-30°C (59°F-86°F)

Inactive ingredients

Lanolin alcohol, Methyl paraben, Paraffin oil, Propyl paraben, Propylene glycol, Purified water, White Petrolatum

Questions or commetns?

Call 1.800.996.5122 (Mon-Fri 9AM-5PM EST)

OCTIQ 
sodium chloride ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 57483-601
Route of Administration	OPHTHALMIC

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SODIUM CHLORIDE (UNII: 451W47IQ8X) (CHLORIDE ION - UNII:Q32ZN48698)	SODIUM CHLORIDE	50 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
LANOLIN ALCOHOLS (UNII: 884C3FA9HE)
METHYLPARABEN (UNII: A2I8C7HI9T)
PARAFFIN (UNII: I9O0E3H2ZE)
PROPYLPARABEN (UNII: Z8IX2SC1OH)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
WATER (UNII: 059QF0KO0R)
WHITE PETROLATUM (UNII: B6E5W8RQJ4)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 57483-601-05	1 in 1 CARTON	11/12/2021	11/12/2021
1		5 g in 1 TUBE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part349	11/12/2021	11/12/2021

Labeler - Innovus Pharmaceuticals, Inc. (962507187)

Establishment
Name	Address	ID/FEI	Business Operations
AMMAN PHARMACEUTICAL INDUSTRIES		534677849	manufacture(57483-601)

Revised: 7/2023

Document Id: 875ca176-e8b4-45ae-9d27-e329b0f860c6

34390-5

Set id: 61fffceb-7f35-45a7-a7b7-c3b31c240fbc

Version: 3

Effective Time: 20230712